Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer

Anticancer Research

Volumn 24, Issue 3 B, 2004, Pages 2101-2105

  Yukawa, Norio ^a   Yoshikawa, Takaki ^b,c   Akaike, Makoto ^b   Sugimasa, Yukio ^b   Takemiya, Shoji ^b   Yanoma, Shunsuke ^b   Imada, Toshio ^a   Noguchi, Yoshikazu ^c  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c Yokohama Kohwan Hospital   (Japan)

Author keywords

Colorectal carcinoma; Plasma; Prognostic value; Tissue inhibitor of matrix metalloproteinase 1

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM METASTASIS; PLASMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SEROSA; TISSUE TYPES;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 3242716061     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tsuchiya Y, Sato H, Endo Y et al: Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line KKLS, in the chick embryo. Cancer Res 53: 1397-1402, 1993.
2. Crawford HC and Matrisian LM: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14: 234-245, 1995.
3. Urbanski SJ, Edwards DR, Hershtield N et al: Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diag Mol Pathol 2: 81-89, 1993.
4. Denhardt TD, Feng B, Edwards DR, Cocuzzi ET and Malyankar UM: Tissue inhibitor of metalloproteinase (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 59: 329-341, 1993.
5. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E and Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298: 29-32, 1992.
6. Zeng ZS, Cohen AM, Zhang ZF, Stetler-Stevenson W and Guillem JG: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res 1: 907-912, 1995.
7. Holten-Andersen MN, Murphy G, Nielsen HJ et al: Quantitation of TIMP-1 in plasma of healthy donors and patients with advanced cancer. Br J Cancer 80: 495-503, 1999.
8. Yukawa N, Yoshikawa T, Akaike M et al: Plasma concentration of tissue inhibitor of matrix metalloproteinase-1 in patients with colorectal carcinoma. Br J Surgery 88: 1596-1601, 2001.
9. Japanese Research Society for Cancer of the Colon and Rectum General Rules for Clinical and Pathological Studies on Cancer of Colon, Rectum, Anus in Japan. Tokyo: Kanehara, Inc., 1998.
10. Kodama S, Iwata K, Iwata H, Yamashita K and Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Methods 127: 103-108, 1990.
11. Sato H, Kida Y, Mai M et al: Expression of x genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7: 77-83, 1992.
12. Joo YE, Seo KS, Kim J et al: Role of tissue inhibitor of metalloproteinase (TIMPs) in colorectal carcinoma. J Korean Med Sci 14: 417-23, 1999.
13. Yoshikawa T, Tsuburaya A, Kobayashi O et al: Prognostic value of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with gastric cancer. Cancer Letters 151: 81-86, 2000.
14. Nomura H, Fujimoto N, Seiki M, Mai M and Okada Y: Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 69: 9-16, 1996.
15. Mimori K, Mori M, Shiraishi T et al: Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer 76: 531-536, 1997.
16. Sobin LH and Fleming ID: TNM classification of malignant tumors. Cancer 80: 1803-1804, 1997.
17. Ismail T, Hallissey M.T and Fielding J.W: Pathologic prognostic factor for gastrointestinal cancer. World J Surg 19: 178-183, 1995.